A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes

Despite advances in understanding autoimmune diabetes in animal models, there has been little progress in altering the natural course of the human disease, which involves progression to insulin deficiency. Studies with immunosuppressive agents have shown short-term effectiveness, but they have not i...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes
Glavni autori: Herold, Kevan C., Gitelman, Stephen E., Masharani, Umesh, Hagopian, William, Bisikirska, Brygida, Donaldson, David, Rother, Kristina, Diamond, Beverly, Harlan, David M., Bluestone, Jeffrey A.
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2005
Teme:
Immunology and Transplantation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5315015/
https://ncbi.nlm.nih.gov/pubmed/15919798
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items